Oxbridge Re Holdings Limited (NASDAQ: OXBR), (the 'Company”), which together with its subsidiaries is engaged in the business of tokenized Real-World Assets ('RWAs”), initially in the form of ...
Q4 2025 earnings: sales up 5.9%, comps +4.3%, margins expand on lower shrink, and FY2026 EPS guided at $7.10–$7.35—read highlights.
Thomas Tuchel names his squad for March friendlies with Harry Maguire, Kobbie Mainoo and Lewis Hall all set for a recall.
Ionis Pharma projects $2B+ peak revenue for Olezarsen, which is highly conservative given the U.S. addressable market. Read ...
With me on today's call are Relmada Therapeutics, Inc.'s CEO, Dr. Sergio Traversa, who will briefly provide a summary of recent business highlights; Dr. Raj S. Pruthi, Relmada Therapeutics, Inc.'s CMO ...
Operator: Good day, everyone, and welcome to the Movado Group, Inc. Fourth Quarter 2026 Earnings Conference Call.
Operator: Good morning, everyone, and welcome to the Solo Brands, Inc. Fourth Quarter and Full Year 2025 Financial Results Conference Call. All participants will be in a listen-only mode.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results